FDA approves first human insulin for veterinary use
FDA approves first human insulin for veterinary use
Nov 20, 2009: The Food and Drug Administration recently approved Boehringer Ingelheim Vetmedica’s PROZINC™ (protamine zinc recombinant human insulin) for veterinary use for cats with diabetes mellitus. PROZINC was created specifically with cats in mind. PROZINC™ is an aqueous protamine zinc (PZI) suspension of recombinant human insulin that is used to reduce hyperglycemia in cats. It is the first recombinant human PZI insulin available for the management of feline diabetes mellitus.
More information: http://www.prozinc.us/how.aspx